The Current Ratio as of December 2024 (TTM) for Collegium Pharmaceutical, Inc. (COLL) is 0.97

According to Collegium Pharmaceutical, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.97. This represents a change of -13.23% compared to the average of 1.11 of the last 4 quarters.

Collegium Pharmaceutical, Inc. (COLL) Historical Current Ratio (quarterly & annually)

How has COLL Current Ratio performed in the past?

The mean historical Current Ratio of Collegium Pharmaceutical, Inc. over the last ten years is 3.65. The current 0.97 Current Ratio has changed 2.55% with respect to the historical average. Over the past ten years (40 quarters), COLL's Current Ratio was at its highest in in the June 2015 quarter at 18.36. The Current Ratio was at its lowest in in the December 2014 quarter at 0.43.

Collegium Pharmaceutical, Inc. (COLL) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Collegium Pharmaceutical, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Collegium Pharmaceutical, Inc. (COLL) Average Current Ratio

How has COLL Current Ratio performed in the past?

The current Current Ratio of Collegium Pharmaceutical, Inc. (COLL) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Collegium Pharmaceutical, Inc. (COLL) Current Ratio vs. Peers

How is COLL’s Current Ratio compared to its peers?

Collegium Pharmaceutical, Inc.’s Current Ratio is less than Phibro Animal Health Corporation (3.23), less than ANI Pharmaceuticals, Inc. (2.74), less than Procaps Group S.A. (1.47), greater than Silver Spike Investment Corp. (0), less than Amphastar Pharmaceuticals, Inc. (3.43), less than Eagle Pharmaceuticals, Inc. (1.70), less than Alkermes plc (3.45), less than Evolus, Inc. (2.47), less than Prestige Consumer Healthcare Inc. (3.56), less than Regencell Bioscience Holdings Limited (41.92), less than Pacira BioSciences, Inc. (2.25), less than Intra-Cellular Therapies, Inc. (7.66), less than Dr. Reddy's Laboratories Limited (1.92),

Build a custom stock screener for Collegium Pharmaceutical, Inc. (COLL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Collegium Pharmaceutical, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Collegium Pharmaceutical, Inc. (COLL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Collegium Pharmaceutical, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.